Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neoadjuvant Chemoimmunotherapy Combined With Surgery Versus Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer: a Multicenter Randomized Controlled Clinical Trial

NCT06288373 is registered in ClinicalTrials.gov with Tongji Hospital as lead sponsor.

NCT NCT06288373
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06288373 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neoadjuvant Chemoimmunotherapy Combined With Surgery Versus Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer: a Multicenter Randomized Controlled Clinical Trial
Lead sponsor
Tongji Hospital
Phase
Phase 2/3
Overall status
Recruiting
Start date
April 22, 2024
Completion date
March 1, 2031
Enrollment
440 (estimated)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

cervical cancer, concurrent chemoradiotherapy, locally advanced cervical cancer, neoadjuvant chemoimmunotherapy